| Jennifer Kunzman, PT, DPT | |
|
180 S Main St Ste C2, Driggs, ID 83422-5034 | |
| (208) 354-3128 | |
| Not Available |
| Full Name | Jennifer Kunzman |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 5 Years |
| Location | 180 S Main St Ste C2, Driggs, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770148280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-7045 (Idaho) | Primary |
| 225100000X | Physical Therapist | PT-1862 (Wyoming) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| High Peaks Physical Therapy P A | 6608821194 | 9 |
News Archive
A new study in the Journal of Nutrition Education and Behavior, published by Elsevier, explores real-time personal and employee safety experiences and perspectives of school nutrition professionals ranging from frontline staff to state leadership across the United States during the early weeks of the coronavirus pandemic.
Acadia Healthcare Company, Inc. today announced that it has signed a definitive purchase agreement with Ten Broeck Tampa, Inc. and Capestrano Investment Company, Inc. to purchase two acute inpatient psychiatric facilities.
Polymedco, Inc. is pleased to announce the direct availability of the BTA stat® test from our sales force – The BTA stat® test is a point of care technology for the early detection of recurrent bladder cancer. This method uses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urine.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 8 days ago
| Provider Name | High Peaks Physical Therapy P A |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356412837 PECOS PAC ID: 6608821194 Enrollment ID: O20050317000468 |
News Archive
A new study in the Journal of Nutrition Education and Behavior, published by Elsevier, explores real-time personal and employee safety experiences and perspectives of school nutrition professionals ranging from frontline staff to state leadership across the United States during the early weeks of the coronavirus pandemic.
Acadia Healthcare Company, Inc. today announced that it has signed a definitive purchase agreement with Ten Broeck Tampa, Inc. and Capestrano Investment Company, Inc. to purchase two acute inpatient psychiatric facilities.
Polymedco, Inc. is pleased to announce the direct availability of the BTA stat® test from our sales force – The BTA stat® test is a point of care technology for the early detection of recurrent bladder cancer. This method uses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urine.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 8 days ago
| Provider Name | Momentum Mobile Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1902679699 PECOS PAC ID: 0446603765 Enrollment ID: O20240201004153 |
News Archive
A new study in the Journal of Nutrition Education and Behavior, published by Elsevier, explores real-time personal and employee safety experiences and perspectives of school nutrition professionals ranging from frontline staff to state leadership across the United States during the early weeks of the coronavirus pandemic.
Acadia Healthcare Company, Inc. today announced that it has signed a definitive purchase agreement with Ten Broeck Tampa, Inc. and Capestrano Investment Company, Inc. to purchase two acute inpatient psychiatric facilities.
Polymedco, Inc. is pleased to announce the direct availability of the BTA stat® test from our sales force – The BTA stat® test is a point of care technology for the early detection of recurrent bladder cancer. This method uses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urine.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Kunzman, PT, DPT 180 S Main St Ste C2, Driggs, ID 83422-5034 Ph: (208) 354-3128 | Jennifer Kunzman, PT, DPT 180 S Main St Ste C2, Driggs, ID 83422-5034 Ph: (208) 354-3128 |
News Archive
A new study in the Journal of Nutrition Education and Behavior, published by Elsevier, explores real-time personal and employee safety experiences and perspectives of school nutrition professionals ranging from frontline staff to state leadership across the United States during the early weeks of the coronavirus pandemic.
Acadia Healthcare Company, Inc. today announced that it has signed a definitive purchase agreement with Ten Broeck Tampa, Inc. and Capestrano Investment Company, Inc. to purchase two acute inpatient psychiatric facilities.
Polymedco, Inc. is pleased to announce the direct availability of the BTA stat® test from our sales force – The BTA stat® test is a point of care technology for the early detection of recurrent bladder cancer. This method uses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urine.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 8 days ago
Emily Renovitch, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 600 Valley Centre Dr, Driggs, ID 83422 Phone: 208-354-0089 | |
Daniel N Streubel, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 285 E Little Ave, Driggs, ID 83422 Phone: 208-354-1999 Fax: 866-875-1249 | |
Jorid Halsnes, DPT, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 180 S Main St, Driggs, ID 83422 Phone: 208-354-3128 | |
Christine Marie Lundberg-bleffert, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Valley Centre Drive, Driggs, ID 83422 Phone: 208-354-0089 Fax: 509-561-0536 | |
Andrew Mayer, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 285 E Little Ave, Driggs, ID 83422 Phone: 208-354-1999 | |
Michelle Bodenhamer, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 50 Ski Hill Rd, Driggs, ID 83422 Phone: 208-354-3128 | |
High Peaks Physical Therapy P A Physical Therapist Medicare: Medicare Enrolled Practice Location: 500 Ski Hill Road, Driggs, ID 83422 Phone: 208-354-3128 Fax: 208-354-3128 |